Optimal care for early RA patients: the challenge of translating scientific data into clinical practice.
about
Wait times to rheumatology care for patients with rheumatic diseases: a data linkage study of primary care electronic medical records and administrative data.General practitioners' perspectives on campaigns to promote rapid help-seeking behaviour at the onset of rheumatoid arthritis.Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosisDecision tool to improve the quality of care in rheumatoid arthritiscDNA phage display for the discovery of theranostic autoantibodies in rheumatoid arthritis.Use of Decision Support for Improved Knowledge, Values Clarification, and Informed Choice in Patients With Rheumatoid Arthritis.Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohortThe optimal combination therapy for the treatment of early rheumatoid arthritis.Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis.Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial.Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.Costs of drugs for treatment of rheumatic diseases.Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis.Social interactions at the onset of rheumatoid arthritis and their influence on help-seeking behaviour: A qualitative exploration.Efficacy and gastrointestinal tolerability of ML3403, a selective inhibitor of p38 MAP kinase and CBS-3595, a dual inhibitor of p38 MAP kinase and phosphodiesterase 4 in CFA-induced arthritis in rats.
P2860
Q31113750-1B95C2F7-4935-43F6-BFCC-515BAD283C06Q34065606-257CD203-BAC6-458C-BE91-AEF80CC9BBA2Q35135825-B1C1A63F-990A-41C7-87EA-E752581D046DQ36032715-15BA1BA9-0092-4072-AB39-C1EB494EB076Q36098311-00EA58FF-D148-4ED5-BB8A-4F9C0D1D1259Q36219817-51225DB9-34D3-4B3B-A3F9-4BF0950D6B3AQ36907691-3FEB12AA-A916-4687-B07E-0ED24061366BQ38522457-CD8F9817-620D-4EC6-A6F1-DF89A355424DQ39246815-EF2D60A3-D9CE-4F73-9024-FBAEEAAE75AAQ40588909-EDD67B40-91EC-461D-AFA5-61B5FBC804E4Q44640038-D2151627-DD1B-428D-A748-62985D366C61Q47164070-D51E044D-9D5F-461A-8CF6-05C2C1ECF452Q47807214-0900191B-B65E-4BB4-9BEC-EF415A817902Q50583345-05FF3524-D3F0-48EC-8158-1C85E9CAA979Q50953564-45F7335B-E49F-4373-A68A-EB1F00C19DBFQ51772071-CE8B812E-D8AC-48DE-B63C-C582A80ED11A
P2860
Optimal care for early RA patients: the challenge of translating scientific data into clinical practice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Optimal care for early RA pati ...... c data into clinical practice.
@ast
Optimal care for early RA pati ...... c data into clinical practice.
@en
type
label
Optimal care for early RA pati ...... c data into clinical practice.
@ast
Optimal care for early RA pati ...... c data into clinical practice.
@en
prefLabel
Optimal care for early RA pati ...... c data into clinical practice.
@ast
Optimal care for early RA pati ...... c data into clinical practice.
@en
P356
P1433
P1476
Optimal care for early RA pati ...... c data into clinical practice.
@en
P2093
René Westhovens
P304
P356
10.1093/RHEUMATOLOGY/KER131
P577
2011-03-30T00:00:00Z